Thread Reader
Jonathan Howard MD

Jonathan Howard MD
@19joho

Nov 16, 2025
1 tweets
Tweet

Quite the medical reversal

NEJM

NEJM
@NEJM

Nov 12 25
View on Twitter
Personalized therapies hold tremendous promise but challenge traditional models of drug and biologic development. The @U.S. FDA outlines a path to market entry for products where a randomized trial is not feasible. Learn more: nej.md/4nUQdcl
Sounding Board "Nearly 30 years after the sequencing of the human genome, bespoke therapies are close to reality. The FDA will work as a partner and guide in ushering these therapies to market, and our regulatory strategies will evolve to match the pace of scientific advances." "FDA’s New Plausible Mechanism Pathway Vinay" by Prasad, M.D., M.P.H., and Martin A. Makary, M.D., M.P.H.
Jonathan Howard MD

Jonathan Howard MD

@19joho
Author: We Want Them Infected: How the Failed Quest for Herd Immunity Led Doctors to Embrace Anti-Vaccine Movement https://t.co/LrW2um1R01
Follow on 𝕏
twitter-thread.com/t/1989884741101994342
Missing some tweets in this thread? Or failed to load images or videos? You can try to .